Trials / Completed
CompletedNCT04694638
Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection
The Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in Acute Hypoxemic and/or Hypercapnic Respiratory Failure Secondary to COVID-19 Infection: A Feasibility, Safety Phase One, Open Label Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 110 Years
- Healthy volunteers
- Not accepted
Summary
This research aims to understand if prone positioning combined with high-flow nasal cannula (HFNC) or non-invasive positive pressure ventilation (NIPPV) safely reduce the rate of intubation in acute hypoxemic and/or hypercapnic respiratory failure secondary to COVID-19 infection.
Conditions
- Prone Positioning
- Covid19
- Hypoxemic Respiratory Failure
- ARDS
- Non Invasive Ventilation
- High Flow Nasal Cannulla
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Body position change | combined use of prone positioning and high-flow nasal cannula (HFNC) and non-invasive positive pressure ventilation (NIPPV) can reduce the rate of intubation in acute hypoxemic and/or hypercapnic respiratory failure secondary to COVID-19 infection. |
Timeline
- Start date
- 2020-05-21
- Primary completion
- 2023-05-10
- Completion
- 2023-05-10
- First posted
- 2021-01-05
- Last updated
- 2023-10-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04694638. Inclusion in this directory is not an endorsement.